12.01.10
Global alternative asset manager The Carlyle Group has completed its $4 billion acquisition of NBTY, a global manufacturer and marketer of nutritional supplements. Pursuant to the terms of the merger agreement, NBTY stockholders are entitled to receive $55 in cash, without interest, less any applicable withholding taxes, for each share of NBTY common stock owned. As a result of the merger, NBTY’s common stock will no longer be listed for trading on the New York Stock Exchange. Equity capital for the transaction came from Carlyle Partners V, a $13.7 billion U.S. buyout fund, and Carlyle Europe Partners III, a €5.4 billion European buyout fund, and debt financing was provided by a syndicate of banks led by BofA Merrill Lynch, Barclays Capital and Credit Suisse.